![]() |
Name |
Tetraethylenepentamine
|
Molecular Formula | C8H23N5 | |
IUPAC Name* |
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine
|
|
SMILES |
C(CNCCNCCNCCN)N
|
|
InChI |
InChI=1S/C8H23N5/c9-1-3-11-5-7-13-8-6-12-4-2-10/h11-13H,1-10H2
|
|
InChIKey |
FAGUFWYHJQFNRV-UHFFFAOYSA-N
|
|
Synonyms |
TETRAETHYLENEPENTAMINE; 112-57-2; Tetren; 1,4,7,10,13-Pentaazatridecane; Tetraethylene pentamine; Tetraethylpentylamine; 1,11-Diamino-3,6,9-triazaundecane; 3,6,9-Triazaundecamethylenediamine; DEH 26; 3,6,9-Triazaundecane-1,11-diamine; Tetrene; NSC 88603; 1,2-Ethanediamine, N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-; 26913-06-4; YZD1C9KQ28; CHEBI:49798; N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine; 1,2-Ethanediamine, N-(2-aminoethyl)-N'-(2-((2-aminoethyl)amino)ethyl)-; N-(2-aminoethyl)-N'-{2-[(2-aminoethyl)amino]ethyl}ethane-1,2-diamine; NSC-88603; NCGC00090964-02; (2-aminoethyl)[2-({2-[(2-aminoethyl)amino]ethyl}amino)ethyl]amine; DSSTox_CID_6108; DSSTox_RID_78020; DSSTox_GSID_26108; TETRAEN; 1,2-Ethanediamine, N1-(2-aminoethyl)-N2-(2-((2-aminoethyl)amino)ethyl)-; 1,2-Ethanediamine, N1-(2-aminoethyl)-N2-[2-[(2-aminoethyl)amino]ethyl]-; n-(2-aminoethyl)-n'-(2-((2-aminoethyl)amino)ethyl)-1,2-ethanediamine; Ancamine TEPA; CAS-112-57-2; PAW; CCRIS 6275; HSDB 5171; EINECS 203-986-2; UN2320; UNII-YZD1C9KQ28; BRN 0506966; AI3-10049; Tetraethylenpentamine; MFCD00008168; Texlin 400; tetraethylene pentaamine; 1,6,9-triazaundecane; INSULCURE 9; N-(2-Aminoethyl)-N-(2-((2-aminoethyl)amino)ethyl-1,2-ethanediamine); Tetraethylenepentamine, CP; Tetraethylenepentamine [UN2320] [Corrosive]; NCIOpen2_001402; SCHEMBL15797; WLN: Z2M2M2M2Z; 4-04-00-01244 (Beilstein Handbook Reference); MLS000028888; BIDD:ER0305; CHEMBL138297; 1,7,10,13-Pentaazatridecane; DTXSID7026108; 3,9-Triazaundecane-1,11-diamine; NSC88603; TETRAETHYLENEPENTAMINE [HSDB]; Tox21_111047; Tox21_200669; D.E.H. 26; STL453738; TH 160; ZINC19363537; AKOS015894482; Tetraethylenepentamine, technical grade; Tox21_111047_1; UN 2320; NCGC00090964-01; NCGC00090964-03; NCGC00090964-04; NCGC00258223-01; SMR000059212; FT-0657261; T0098; 3,6,9-TRIAZA-1,11-DIAMINOUNDECANE; BIS(2-(2-AMINOETHYLAMINO)ETHYL)AMINE; EN300-268351; Tetraethylenepentamine [UN2320] [Corrosive]; AB00375928_03; SR-01000944425; T-11509; J-503958; SR-01000944425-1; BRD-K41298358-395-01-8; Q15974770; 1, N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-; N1-(2-aminoethyl)-N2-(2-(2-aminoethylamino)ethyl)ethane-1,2-diamine; N1-{2-[2-(2-AMINO-ETHYLAMINO)-ETHYLAMINO]-ETHYL}-ETHANE-1,2-DIAMINE
|
|
CAS | 112-57-2 | |
PubChem CID | 8197 | |
ChEMBL ID | CHEMBL138297 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 189.3 | ALogp: | -2.9 |
HBD: | 5 | HBA: | 5 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 88.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.264 |
Caco-2 Permeability: | -6.269 | MDCK Permeability: | 0.00000346 |
Pgp-inhibitor: | 0.081 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.126 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.019 |
Blood-Brain-Barrier Penetration (BBB): | 0.05 | Plasma Protein Binding (PPB): | 42.85% |
Volume Distribution (VD): | 0.32 | Fu: | 63.81% |
CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.018 |
CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.122 |
CYP2C9-inhibitor: | 0 | CYP2C9-substrate: | 0.03 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.612 |
CYP3A4-inhibitor: | 0.001 | CYP3A4-substrate: | 0.194 |
Clearance (CL): | 4.422 | Half-life (T1/2): | 0.276 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.187 |
Drug-inuced Liver Injury (DILI): | 0.017 | AMES Toxicity: | 0.316 |
Rat Oral Acute Toxicity: | 0.127 | Maximum Recommended Daily Dose: | 0.055 |
Skin Sensitization: | 0.953 | Carcinogencity: | 0.008 |
Eye Corrosion: | 0.988 | Eye Irritation: | 0.055 |
Respiratory Toxicity: | 0.56 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000257 | ![]() |
0.191 | D0GJ8R | ![]() |
0.974 | ||
ENC000931 | ![]() |
0.167 | D09VAZ | ![]() |
0.757 | ||
ENC002001 | ![]() |
0.152 | D09VOK | ![]() |
0.718 | ||
ENC001177 | ![]() |
0.150 | D06CIE | ![]() |
0.232 | ||
ENC000722 | ![]() |
0.148 | D0R3JB | ![]() |
0.221 | ||
ENC000123 | ![]() |
0.145 | D0UP9M | ![]() |
0.211 | ||
ENC000621 | ![]() |
0.145 | D0V7XF | ![]() |
0.189 | ||
ENC006103 | ![]() |
0.145 | D08QME | ![]() |
0.154 | ||
ENC000542 | ![]() |
0.140 | D0FD0H | ![]() |
0.151 | ||
ENC000493 | ![]() |
0.140 | D0AY9Q | ![]() |
0.145 |